Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders

被引：4

作者：

Callen, JP ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40202 USA

来源：

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY | 2001年 / 20卷 / 01期

关键词：

D O I：

10.1053/sder.2001.23100

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Cytotoxic and immunosuppressive drugs ore regularly used to treat proliferative, immunologically mediated inflammatory disorders and some neoplastic diseases of the skin. Methotrexate, azathioprine, mycophenolate mofetil, cyclosporin cyclophosphamide, chlorambucil, and other related drugs have potential benefits in the treatment of severe and/or recalcitrant rheumatic skin diseases, The therapeutic window for these agents is narrow. The major uses of these drugs am for life-threatening cutaneous disorders or as steroid-sparing agents. Copyright (C) 2001 by W.B. Saunders Company.

引用

页码：58 / 67

页数：10

共 57 条

[31] LOW-DOSE WEEKLY METHOTREXATE FOR UNUSUAL NEUTROPHILIC VASCULAR REACTIONS - CUTANEOUS POLYARTERITIS-NODOSA AND BEHCETS-DISEASE [J].

JORIZZO, JL ;

WHITE, WL ;

WISE, CM ;

ZANOLLI, MD ;

SHERERTZ, EF .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (06) :973-978

[32]

JOST CR, 1990, BLOOD, V75, P144

[33] REVERSIBLE LYMPHOMAS ASSOCIATED WITH EPSTEIN-BARR-VIRUS OCCURRING DURING METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS AND DERMATOMYOSITIS [J].

KAMEL, OW ;

VANDERIJN, M ;

WEISS, LM ;

DELZOPPO, GJ ;

HENCH, PK ;

ROBBINS, BA ;

MONTGOMERY, PG ;

WARNKE, RA ;

DORFMAN, RF .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1317-1321

[34] Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis [J].

Kasteler, JS ;

Callen, JP .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (01) :67-71

[35] AZATHIOPRINE-INDUCED ACUTE PANCREATITIS [J].

KAWANISHI, H ;

RUDOLPH, E ;

BULL, FE .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (07) :357-357

[36] AZATHIOPRINE HYPERSENSITIVITY-LIKE REACTIONS - A CASE-REPORT AND A REVIEW OF THE LITERATURE [J].

KNOWLES, SR ;

GUPTA, AK ;

SHEAR, NH ;

SAUDER, D .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (04) :353-356

[37] LOW INCIDENCE OF HEPATOTOXICITY ASSOCIATED WITH LONG-TERM, LOW-DOSE ORAL METHOTREXATE IN TREATMENT OF REFRACTORY PSORIASIS, PSORIATIC-ARTHRITIS, AND RHEUMATOID-ARTHRITIS - AN ACCEPTABLE RISK BENEFIT RATIO [J].

LANSE, SB ;

ARNOLD, GL ;

GOWANS, JDC ;

KAPLAN, MM .

DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (02) :104-109

[38] PROLONGED USE OF METHOTREXATE FOR SARCOIDOSIS [J].

LOWER, EE ;

BAUGHMAN, RP .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (08) :846-851

[39] POLYMYOSITIS AND DERMATOMYOSITIS - COMBINED METHOTREXATE AND CORTICOSTEROID-THERAPY [J].

METZGER, AL ;

BOHAN, A ;

GOLDBERG, LS ;

BLUESTONE, R ;

PEARSON, CM .

ANNALS OF INTERNAL MEDICINE, 1974, 81 (02) :182-189

[40] Therapy-resistant pyoderma gangrenosum - treatment with mycophenolate mofetil and cyclosporine A [J].

Michel, S ;

Hohenleutner, U ;

Mohr, V ;

Landthaler, M .

HAUTARZT, 1999, 50 (06) :428-431

← 1 2 3 4 5 6 →